BiotechTube
Home/Coya Therapeutics/Dr. Stanley H. Appel
DS

Dr. Stanley H. Appel

Co-founder and Chairman Emeritus

Coya Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesAutoimmune DisordersMetabolic Diseases

Coya Therapeutics Pipeline

DrugIndicationPhase
COYA 302Amyotrophic Lateral Sclerosis (ALS)Phase 2
COYA 201Undisclosed Inflammatory IndicationsPreclinical
COYA 101Undisclosed Autoimmune IndicationsPreclinical

Leadership Team at Coya Therapeutics

DH
Dr. Howard Berman
Executive Chairman of the Board
DA
Dr. Arun Swaminathan
Chief Executive Officer
DF
Dr. Fred Grossman
Chief Medical Officer
AM
Ann Maurer
Chief Financial Officer
View full Coya Therapeutics profile